China XLX Fertiliser : UPDATE ON THE INVESTMENT AGREEMENTS
September 18, 2019 at 08:17 am EDT
Share
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
CHINA XLX FERTILISER LTD.
中國心連心化肥有限公司*
(Incorporated in Singapore with limited liability)
(Hong Kong Stock Code: 1866)
UPDATE ON THE INVESTMENT AGREEMENTS
Reference is made to the announcement and circular of China XLX Fertiliser Ltd. (the "Company") dated 11 June 2019 and 31 July 2019, respectively, in relation to the deemed disposal of Henan XLX. Unless otherwise specified, capitalised terms used in this announcement shall have the same meanings as those defined in the circular.
The Board is pleased to announce that as at 18 September 2019, all payments of subscription amounts by each of the Investors set out below have been received by Henan XLX and Henan XLX raised an aggregate amount of RMB796,500,000 from the Investors as follows:
Name of the Investor
Subscription Amount
(RMB'000)
CCB
200,000
Shanghai Jinpu Guotiao
100,000
Xiamen Baodarun
100,000
Tonglingshi Lingtong
160,000
Ningbo Yuannian
73,520
Shanghai Xinchi
31,640
Shanghai Xinyuan
21,640
Shanghai Xinzheng
65,200
Shanghai Xinzu
38,000
Zhuhai Hengqin
6,500
Total
796,500
- 1 -
Completion will take place upon Henan XLX having updated with the local Administration for Industry and Commerce its latest shareholding structure as follows (including the Investors set out below and the existing shareholders of Henan XLX which hold more than 5%):
Number of
Shareholding
Shareholders of Henan XLX
shares held
percentage
(approximately)
The Company
1,446,355,000
78.37%
Haitong Innovation Securities
100,000,000
5.42%
Ningbo Yuannian
58,830,000
3.19%
CCB
50,000,000
2.71%
Tonglingshi Lingtong
40,000,000
2.17%
Shanghai Jinpu Guotiao
25,000,000
1.36%
Xiamen Baodarun
25,000,000
1.36%
Shanghai Xinzheng
16,300,000
0.88%
Shanghai Xinzu
9,500,000
0.51%
Shanghai Xinchi
7,910,000
0.43%
Shanghai Xinyuan
5,410,000
0.29%
Zhuhai Hengqin
1,625,000
0.09%
The other existing shareholders of Henan XLX prior
to the Investments (other than the Company,
Haitong Innovation Securities and Ningbo Yuannian)
59,550,000
3.22%
Total
1,845,480,000
100.00%
By Order of the Board
China XLX Fertiliser Ltd.
Yan Yunhua
Executive Director
18 September 2019
As at the date of this announcement, the executive directors of the Company are Mr. Liu Xingxu, Mr. Zhang Qingjin and Ms. Yan Yunhua; the independent non-executive directors of the Company are Mr. Ong Kian Guan, Mr. Li Shengxiao, Mr. Ong Wei Jin and Mr. Li Hongxing; and the non- executive director of the Company is Mr. Zheng Jiaqi.
* for identification purpose only
- 2 -
Attachments
Original document
Permalink
Disclaimer
China XLX Fertiliser Ltd. published this content on 18 September 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 September 2019 12:16:02 UTC
China Xlx Fertiliser Ltd is an investment holding company. The Company operates through eight segments. The Manufacturing and Sale of Urea segment is engaged in the manufacturing and sale of urea. The Manufacturing and Sale of Compound Fertiliser segment is engaged in the manufacturing and sale of compound fertiliser. The Manufacturing and Sale of DMF segment is engaged in the manufacturing and sale of DMF. The Manufacturing and Sale of Methanol segment is engaged in the manufacturing and sale of methanol. The Manufacturing and Sale of Melamine segment is engaged in the manufacturing and sale of melamine. The Manufacturing and Sale of Urea Solution for Vehicle segment is engaged in the manufacturing and sale of urea solution for vehicle. The Manufacturing and Sale of Liquid Ammonia segment is engaged in the manufacturing and sale of liquid ammonia. The Manufacturing and Sale of Medical Intermediate segment is engaged in the manufacturing and sale of medical intermediate.